Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Mallinckrodt
AstraZeneca
Johnson and Johnson
Baxter

Last Updated: May 27, 2022

CLINICAL TRIALS PROFILE FOR REVATIO


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Revatio

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00359736 ↗ Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis Completed VA Office of Research and Development Phase 2 2006-07-01 Medicines that decrease blood pressure in the lungs may help idiopathic pulmonary fibrosis (IPF) patients function better. This study will test whether sildenafil improves the ability to exercise in patients with pulmonary fibrosis of unknown cause.
NCT00452218 ↗ Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH) Completed Bayer Phase 1 2007-03-01 The purpose of this study is to assess the safety and tolerability of sorafenib in patients with PAH already on existing therapy with a prostacyclin [epoprostenol (Flolan)], treprostinil (Remodulin), or iloprost alone, or with or without sildenafil (Viagra/Revatio).
NCT00452218 ↗ Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH) Completed University of Chicago Phase 1 2007-03-01 The purpose of this study is to assess the safety and tolerability of sorafenib in patients with PAH already on existing therapy with a prostacyclin [epoprostenol (Flolan)], treprostinil (Remodulin), or iloprost alone, or with or without sildenafil (Viagra/Revatio).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Revatio

Condition Name

Condition Name for Revatio
Intervention Trials
Pulmonary Arterial Hypertension 9
Pulmonary Hypertension 7
Hypertension, Pulmonary 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Revatio
Intervention Trials
Hypertension 24
Hypertension, Pulmonary 17
Pulmonary Arterial Hypertension 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Revatio

Trials by Country

Trials by Country for Revatio
Location Trials
United States 120
Germany 18
Canada 14
Spain 8
Belgium 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Revatio
Location Trials
North Carolina 10
California 8
New York 7
Texas 6
Ohio 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Revatio

Clinical Trial Phase

Clinical Trial Phase for Revatio
Clinical Trial Phase Trials
Phase 4 9
Phase 3 10
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Revatio
Clinical Trial Phase Trials
Completed 41
Terminated 9
Recruiting 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Revatio

Sponsor Name

Sponsor Name for Revatio
Sponsor Trials
Pfizer 17
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 8
National Heart, Lung, and Blood Institute (NHLBI) 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Revatio
Sponsor Trials
Other 78
Industry 36
NIH 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Johnson and Johnson
Boehringer Ingelheim
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.